Austin Gurney
2017
In 2017, Austin Gurney earned a total compensation of $1.4M as Chief Scientific Officer, Senior Vice President, Research at OncoMed Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $116,996 |
|---|---|
| Option Awards | $804,964 |
| Salary | $365,612 |
| Stock Awards | $154,536 |
| Total | $1,442,108 |
Gurney received $805K in option awards, accounting for 56% of the total pay in 2017.
Gurney also received $117K in non-equity incentive plan, $365.6K in salary and $154.5K in stock awards.
Rankings
In 2017, Austin Gurney's compensation ranked 7,201st out of 14,666 executives tracked by ExecPay. In other words, Gurney earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,201 out of 14,666 | 51st |
Division Manufacturing | 2,677 out of 5,768 | 54th |
Major group Chemicals And Allied Products | 874 out of 2,074 | 58th |
Industry group Drugs | 682 out of 1,730 | 61st |
Industry Pharmaceutical Preparations | 535 out of 1,329 | 60th |
Source: SEC filing on April 27, 2018.
Gurney's colleagues
We found four more compensation records of executives who worked with Austin Gurney at OncoMed Pharmaceuticals in 2017.